Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

ADX:JULPHAR Ratios and Metrics

Market cap in millions AED. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 21, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	1,225	1,352	1,502	888	1,340	2,126
Market Cap Growth	-23.19%	-10.00%	69.05%	-33.71%	-36.96%	38.35%
Enterprise Value	1,248	1,381	2,396	1,820	2,114	2,768
Last Close Price	1.06	1.17	1.30	0.77	1.16	1.84
PE Ratio	17.60	7.85	33.67	-	-	33.01
PS Ratio	1.15	1.26	1.51	0.70	0.83	1.86
PB Ratio	1.24	1.41	1.88	1.10	1.44	2.21
P/TBV Ratio	1.30	1.48	2.12	1.37	1.77	2.73
P/FCF Ratio	12.80	15.86	10.27	12.43	-	1180.90
P/OCF Ratio	9.25	11.18	7.90	9.49	69.43	46.01
EV/Sales Ratio	1.17	1.28	2.42	1.43	1.31	2.42
EV/EBITDA Ratio	9.92	14.06	17.34	24.30	31.78	21.54
EV/EBIT Ratio	17.10	25.48	52.09	-	-	66.70
EV/FCF Ratio	13.04	16.21	16.38	25.46	-	1537.84
Debt / Equity Ratio	0.28	0.29	1.22	1.38	0.95	0.85
Debt / EBITDA Ratio	2.18	2.45	5.35	9.48	8.57	5.60
Debt / FCF Ratio	2.87	3.23	6.64	15.53	-	455.06
Net Debt / Equity Ratio	0.01	0.01	1.00	1.10	0.83	0.66
Net Debt / EBITDA Ratio	0.11	0.07	5.81	11.82	11.64	4.98
Net Debt / FCF Ratio	0.13	0.08	5.49	12.38	-17.43	355.72
Asset Turnover	0.55	0.51	0.41	0.53	0.67	0.48
Inventory Turnover	1.54	1.48	1.04	1.28	1.60	1.60
Quick Ratio	1.55	1.62	1.11	1.13	1.17	1.18
Current Ratio	2.86	3.12	2.26	2.26	2.44	2.32
Return on Equity (ROE)	7.31%	4.99%	-1.16%	-8.75%	-3.83%	4.08%
Return on Assets (ROA)	2.34%	1.61%	1.18%	-0.63%	-0.74%	1.09%
Return on Invested Capital (ROIC)	6.90%	3.91%	2.79%	-1.44%	-1.73%	2.53%
Return on Capital Employed (ROCE)	5.60%	4.20%	3.00%	-1.40%	-1.60%	2.30%
Earnings Yield	6.65%	12.74%	2.97%	-11.15%	-2.19%	3.03%
FCF Yield	7.82%	6.30%	9.74%	8.05%	-3.31%	0.08%
Buyback Yield / Dilution	-	-	-	-	-	-9.21%
Total Shareholder Return	-	-	-	-	-	-9.21%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.